Series C funding round for Edgewise Therapeutics raising $95M in December 2020
Series C funding round for Edgewise Therapeutics raising $95M in December 2020
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Robert Garland | |
| Angel | Carol Gallagher |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$145M
Top Valuation
-
Edgewise Therapeutics raised $95M in a Series C round.
The round was announced on 12/01/20.
The round was led by Viking Global Investors.